Kardiochirurgia i Torakochirurgia Polska

Full text

2/2026 vol. 23
Review paper

Introducing palliative care into the management of patients disqualified from transcatheter aortic valve implantation

Sebastian Woźniak 1
,
Michał Graczyk 2
,
Katarzyna B. Mądra-Gackowska 3
,
Wiktor Budniak 1
,
Justyna Jaraczewska 1
,
Grzegorz Lau 1
,
Anna Adamczyk 2
,
Remigiusz Tomczyk 1, 4
,
Marcin Gackowski 5

  1. Department of Cardiology and Cardiac Surgery, 10th Military Research Hospital and Polyclinic, Bydgoszcz, Poland

  2. Department of Palliative Care, Faculty of Health Science, L. Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland

  3. Department of Geriatrics, Faculty of Health Science, L. Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland

  4. Faculty of Medicine, University of Science and Technology, Bydgoszcz, Poland

  5. Department of Toxicology and Bromatology, Faculty of Pharmacy, L. Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland

Kardiochirurgia i Torakochirurgia Polska 2026; 23 (2): 163-169

DOI: https://doi.org/10.5114/kitp.2026.163271
Data publikacji online: 2026/07/21
Article file
Introducing palliative.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc 2010; 85: 483-500.
  2. Lindman BR, Bonow RO, Otto CM. Current management of calcific aortic stenosis. Circ Res 2013; 113: 223-237.
  3. Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, Ajmone Marsan N, Barili F, Bonaros N, Cosyns B, De Paulis R, Gamra H, Jahangiri M, Jeppsson A, Klautz RJM, Mores B, Pérez-David E, Pöss J, Prendergast BD, Rocca B, Rossello X, Suzuki M, Thiele H, Tribouilloy CM, Wojakowski W; ESC/EACTS Scientific Document Group. 2025 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J 2025; 46: 4635-4736.
  4. Zembala M, Wilczek K, Przybylski R, Chodór P, Nadziakiewicz P, Krasoñ M, Sadowski J, Dudek D, Kapelak B, Forysz D, Witkowski A, Demkow M, Chmielak Z, Kuœmierski K, Juraszyñski Z, Bochenek A, Cisowski M, Trusz-Gluza M, Buszman P, Woœ S, Kalarus Z, Poloñski L, G¹sior M, Opolski G, Ru¿y³³o W. Raport Pol-Tavi First z zastosowania przezcewnikowej implantacji zastawki aortalnej typu Edwards-Sapien u pierwszych w Polsce 19 chorych z grupy bardzo du¿ego ryzyka, z ciê¿k¹ stenoz¹ aortaln¹ i chorobami obci¹¿aj¹cymi rokowanie. Kardiochir Torakochir Pol 2009; 6: 219-223.
  5. Siudak Z, Huczek Z, Grygier M, Tomaniak M, Ka³u¿na-Oleksy M, Kleczyñski P, Milewski K, Opolski MP, Smolka G, Sabiniewicz R, Malinowski KP, Dudek D, Huczek Z, Hawranek M. Interventional Cardiology in Poland in 2024. Annual Summary Report of the Association of Cardiovascular Interventions of the Polish Cardiac Society (AISN PTK) and Jagiellonian University Medical College. Adv Interv Cardiol 2025; 21: 469-472.
  6. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt 3rd TM, Thomas JD; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. Circulation 2014; 129: 2440-2492.
  7. Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, Deeb GM, Thourani VH, Cohen DJ, Desai N, Kirtane AJ, Fitzgerald S, Michaels J, Krohn C, Masoudi FA, Brindis RG, Bavaria JE. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol 2020; 76: 2492-2516.
  8. Fairbairn T, Kemp I, Young A, Ronayne C, Barton J, Crowe J, McQuade L, Clarkson N, Sionas M, Tobin A. Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. JAMA 2022; 327: 1875-1887.
  9. Mack MJ, Leon MB, Thourani VH, Pibarot P, Hahn RT, Genereux P, Kodali SK, Kapadia SR, Cohen DJ, Pocock SJ, Lu M, White R, Szerlip M, Ternacle J, Malaisrie SC, Herrmann HC, Szeto WY, Russo MJ, Babaliaros V, Smith CR, Blanke P, Webb JG, Makkar R; PARTNER 3 Investigators. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med 2023; 389: 1949-1960.
  10. Arnold SV, Afilalo J, Spertus JA, Tang Y, Baron SJ, Jones PG, Reardon MJ, Yakubov SJ, Adams DH, Cohen DJ. Prediction of poor outcome after transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 68: 1868-1877.
  11. Lindman BR, Alexander KP, O’Gara PT, Afilalo J. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Interv 2014; 7: 707-716.
  12. Schoenenberger AW, Stortecky S, Neumann S, Moser A, Juni P, Carrel T, Huber C, Gandon M, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S, Wenaweser P. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J 2013; 34: 684-692.
  13. Arnold SV, Reynolds MR, Lei Y, Magnuson EA, Kirtane AJ, Kodali SK, Zajarias A, Thourani VH, Green P, Rodés-Cabau J, Beohar N, Mack MJ, Leon MB, Co- hen DJ; PARTNER Investigators. Predictors of poor outcomes after transcathe­ter aortic valve replacement. Circulation 2014; 129: 2682-2690.
  14. Ferry C, Fiery-Fraillon J, Togni M, Cook S. Futility in TAVI: a scoping review of definitions, predictive criteria, and medical predictive models. PLoS One 2025; 20: e0313399.
  15. Webb J, Rodés-Cabau J, Fremes S, Pibarot P, Ruel M, Ibrahim R, Welsh R, Feindel C, Lichtenstein S. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society Position Statement. Can J Cardiol 2012; 28: 520-528.
  16. Ryder M, Beattie JM, O’Hanlon R, McDonald K. Multidisciplinary heart failure management and end of life care. Curr Opin Support Palliat Care 2011; 5: 317-321.
  17. Whellan DJ, Goodlin SJ, Dickinson MG, Heidenreich PA, Jaenicke C, Stough WG, Rich MW. End-of-life care in patients with heart failure. J Card Fail 2014; 20: 121-134.
  18. Fendler TJ, Swetz KM, Allen LA. Team-based palliative and end-of-life care for heart failure. Heart Fail Clin 2015; 11: 479-498.
  19. Brännström M, Boman K. Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study. Eur J Heart Fail 2014; 16: 1142-1151.
  20. O’Donnell AE, Schaefer KG, Stevenson LW, DeVoe K, Walsh K, Mehra MR, Desai AS. Social worker–aided palliative care intervention in high-risk patients with heart failure (SWAP-HF). JAMA Cardiol 2018; 3: 516-519.
  21. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ. Morphine for the relief of breathlessness in patients with chronic heart failure – a pilot study. Eur J Heart Fail 2002; 4: 753-756.
  22. Oxberry SG, Bland JM, Clark AL, Cleland JG, Johnson MJ. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough. J Palliat Med 2013; 16: 250-255.
  23. Blinderman CD, Billings JA. Comfort care for patients dying in the hospital. N Engl J Med 2015; 373: 2549-2561.
  24. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L; EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006; 27: 2725-2736.
  25. World Health Assembly. WHA67.19 Strengthening of Palliative Care as a Component of Comprehensive Care throughout the Life Course. World Heal Organ 2014, 1–5.
  26. Lauck SB, Gibson JA, Baumbusch J, Carroll SL, Achtem L, Kimel G, Nordquist C, Cheung, A, Boone RH, Ye J, Ye J, Wood DA, Webb JG. Transition to palliative care when transcatheter aortic valve implantation is not an option. Curr Opin Support Palliat Care 2016; 10: 18-23.
  27. Nordgren L, Sörensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs 2003; 2: 213-217.
  28. Denvir MA, Murray SA, Boyd KJ. Future care planning: a first step to palliative care for all patients with advanced heart disease. Heart 2015; 101: 1002-1007.
  29. (CHPC-NG), T.C.N.A. (CNA); the C.H.P.C.A. (CHPCA) and the C.H.P.C.N.G. The Palliative Approach to Care and the Role of the Nurse: A Joint Position Statement.
  30. Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J 2008; 25: 205-209.
  31. Gil V, Domínguez-Rodríguez A, Masip J, Peacock WF, Miró Ò. Morphine use in the treatment of acute cardiogenic pulmonary edema and its effects on patient outcome: a systematic review. Curr Heart Fail Rep 2019; 16: 81-88.
  32. Miró Ò, Gil V, Martín-Sánchez FJ, Herrero-Puente P, Jacob J, Mebazaa A, Harjola VP, Ríos J, Hollander JE, Peacock WF, Llorens W. Morphine use in the ED and outcomes of patients with acute heart failure. Chest 2017; 152: 821-832.
  33. Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE. Palliative care in the treatment of advanced heart failure. Circulation 2009; 120: 2597-2606.
  34. Greater Manchester Integrated Care Partnership Palliative Care Pain & Symptom Control Guidelines for Adults For Staff Providing Generalist Palliative Care 2025, 1-128.
  35. Ströhle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm 2009; 116: 777-784.
  36. Harris JD. Fatigue in chronically ill patients. Curr Opin Support Palliat Care 2008; 2: 180-186.
  37. Ponikowski P, Anker SD, Chua TP, Francis D, Banasiak W, Poole-Wilson PA, Coats AJS, Piepoli M. Oscillatory breathing patterns during wakefulness in patients with chronic heart failure. Circulation 1999; 100: 2418-2424.
  38. Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WHW. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 2008; 14: 508-514.
  39. NHS Neuropathic Pain in Adults-Guideline for Primary Care 2022, 1–22.
  40. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-838.
  41. Naczelna Izba Lekarska Kodeks Etyki Lekarskiej (Code of Medical Ethics) 2025.
Copyright: © 2026 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications